| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |